Bio-AMD Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2011
2012
2013
2014
2015
Cost of Goods Sold (COGS) incl. D&A
7.50
0.60
0.50
0.60
0.10
Gross Income
7.50
0.60
0.50
0.60
0.10
SG&A Expense
2,884.90
1,121.50
1,128.00
1,195.10
911.30
EBIT
2,892.40
1,122.10
1,128.60
1,195.70
911.40
Non Operating Income/Expense
-
216.50
129.20
59.20
77.70
Pretax Income
287.90
892.30
994.30
1,131.10
831.00
Consolidated Net Income
287.90
892.30
994.30
1,131.10
831.00
Net Income
4.30
752.40
896.30
968.80
803.70
Net Income After Extraordinaries
582.20
752.40
896.30
968.80
803.70
Net Income Available to Common
1.20
752.40
896.30
968.80
803.70
EPS (Basic)
0.01
0.02
0.02
0.02
0.02
Basic Shares Outstanding
44,526.00
44,526.00
44,526.00
44,526.00
45,445.40
EPS (Diluted)
0.01
0.02
0.02
0.02
0.02
Diluted Shares Outstanding
46,086.00
44,526.00
44,526.00
44,526.00
45,445.40
EBITDA
2,887.90
1,121.50
1,128.00
1,195.10
911.30
Non-Operating Interest Income
2,604.50
13.30
5.10
5.40
2.80
Minority Interest Expense
292.20
139.90
98.00
162.40
27.30

About Bio-AMD

View Profile
Address
Sci-Tech Daresbury
Daresbury Cheshire WA4 4FS
United Kingdom
Employees -
Website http://www.bioamd.com
Updated 09/14/2018
Bio-AMD, Inc. is a medical technology company, which focuses on Point of Care market. The company operates its business through the WOCU Limited and Bio-AMD Holdings segments. The WOCU Limited segment develops a technology designed to mitigate currency risk.